Osteosarcopenia: Prevalence and 10-Year Fracture and Mortality Risk – A Longitudinal, Population-Based Study of 75-Year-Old Women

Tine Kolenda Paulin,Linnea Malmgren,Fiona E McGuigan,Kristina E Akesson

DOI: https://doi.org/10.1007/s00223-023-01181-1

2024-02-03

Calcified Tissue International

Abstract:Osteosarcopenia is the coexistence of low bone mass and sarcopenia. In older women, its prevalence is not well described, and it is unknown if sarcopenia is additive to low bone mass for fracture and mortality risk. The study investigated prevalence of osteosarcopenia and if osteosarcopenia is associated with higher fracture and mortality risk than low bone mass alone in older community-dwelling women. The longitudinal, population-based OPRA Cohort ( n = 1044), all aged 75 at inclusion, followed for 10 years. Using WHO and EWGSOP2 definitions for low bone mass (T-score < −1.0 femoral neck) and sarcopenia (knee strength; appendicular lean muscle mass) women were categorized (1) Normal, (2) Low bone mass (LBM), and 3) Osteosarcopenia (probable; confirmed). Risk of hip, major osteoporotic fracture, and mortality were estimated. Osteosarcopenia confirmed prevalence increased from age 75 to 80 and 85 from 3.0% (29/970) to 4.9% (32/656) to 9.2% (33/358) but prevalence is potentially 2–4 times higher (11.8%, 13.4%, 20.3%) based on osteosarcopenia probable . Having osteosarcopenia probable significantly increased 10-year risk of hip fracture (HR adj 2.67 [1.34–5.32]), major osteoporotic fracture (HR adj 2.04 [1.27–3.27]), and mortality (HR adj 1.91 [1.21–3.04]). In contrast, LBM increased osteoporotic fracture risk (HR adj 2.08 [1.46–2.97], but not hip fracture (HR adj 1.62 [0.92–2.85]) or mortality (HR adj 0.94 [0.64–1.38]). Median time-to-hip fracture was 7.6 years (normal), 6.0 years (LBM), and 5.7 years (osteosarcopenia probable ). Prevalence of confirmed osteosarcopenia is almost 10% at age 85. Probable osteosarcopenia significantly increased risk of hip and major osteoporotic fractures and mortality more so than low bone mass alone.

endocrinology & metabolism

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly focus on the following aspects:

1. **Determining the prevalence of osteosarcopenia (OS)**: The study aims to determine the prevalence of osteosarcopenia at the ages of 75, 80 and 85 in community - dwelling elderly women. Osteosarcopenia refers to the co - existence of low bone mass (osteoporosis or osteopenia) and sarcopenia.

2. **Evaluating the relationship between osteosarcopenia and the risks of fracture and death**: The study further explores whether osteosarcopenia has a greater impact on the risks of hip fracture, major osteoporotic fracture and death than low bone mass (osteoporosis or osteopenia) alone.

### Research Background
With the rapid increase of the global elderly population, promoting healthy aging has become extremely important. Osteoporosis and sarcopenia are age - related musculoskeletal diseases, which can lead to falls and fractures, and then lead to hospitalization, immobilization, frailty, institutionalization and death. Osteosarcopenia is a relatively new concept, emphasizing the interaction between bone and muscle and its impact on fractures.

### Research Methods
- **Research sample**: The research subjects were from the OPRA cohort in Malmö, Sweden, a total of 1,044 community - dwelling elderly women aged 75.
- **Follow - up time**: The study carried out a 10 - year follow - up, and data were collected at the ages of 75, 80 and 85 respectively.
- **Definitions**:
- **Low bone mass**: Femoral neck T - score < −1.0.
- **Sarcopenia**: According to the definition of the European Working Group on Sarcopenia in Older People (EWGSOP2), including low muscle strength and low muscle mass.
- **Osteosarcopenia**: Low bone mass plus confirmed or possible sarcopenia.
- **Statistical analysis**: The Cox proportional hazards model was used to calculate the risks of the first hip fracture, major osteoporotic fracture and death within 10 years, and adjusted analyses were carried out.

### Main Results
- **Prevalence**:
- The prevalence of confirmed osteosarcopenia increased from 3.0% at the age of 75 to 9.2% at the age of 85.
- If possible osteosarcopenia was included, the prevalence was higher, which were 11.8%, 13.4% and 20.3% respectively.
- **Fracture risk**:
- The 10 - year hip fracture risk in the osteosarcopenia group was significantly higher than that in the normal group (adjusted HR 2.67 [1.34–5.32]).
- The major osteoporotic fracture risk in the osteosarcopenia group was also significantly higher than that in the normal group (adjusted HR 2.04 [1.27–3.27]).
- **Death risk**:
- The 10 - year death risk in the osteosarcopenia group was significantly higher than that in the normal group (adjusted HR 1.91 [1.21–3.04]).
- The death risk in the low bone mass group did not increase significantly (adjusted HR 0.94 [0.64–1.38]).

### Conclusion
This study shows that the prevalence of osteosarcopenia in community - dwelling elderly women increases with age, and is associated with higher risks of hip fracture, major osteoporotic fracture and death. These findings emphasize the importance of screening and evaluating muscle parameters in elderly women, and the necessity of preventing falls to maintain musculoskeletal health.